Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK Tax Perks Lure £500m GSK Investment

This article was originally published in The Pink Sheet Daily

Executive Summary

GSK responds to proposed U.K. tax changes by investing £500 million in manufacturing and setting up a U.K.-targeted venture capital fund

You may also be interested in...



GSK Applauds U.K.'s Tax Changes, Announces New Jobs And Manufacturing Facilities

GlaxoSmithKline is to invest £500 million in new U.K. manufacturing facilities in Ulverston, Montrose and Irvine, creating 1,000 jobs in the process.

Proposed U.K. Budget Boost To Benefit Drug Industry

Amid drastic cuts in public-sector spending, the new U.K. government wants tax and regulatory changes to improve the environment for Big Pharma and biotech.

Proposed U.K. Budget Boost To Benefit Drug Industry

Amid drastic cuts in public-sector spending, the new U.K. government wants tax and regulatory changes to improve the environment for Big Pharma and biotech.

Topics

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel